The approval for the orphan drug designation of VascoStem, a stem cell treatment agent for Buerger’s disease, postponed to January 23, 2016

The approval for the orphan drug designation of VascoStem, a stem cell treatment agent for Buerger’s disease, postponed to January 23, 2016

Biostar Stem Cell Research Institute, jointly run by Nature Cell and R Bio, announced on December 30 that it was requested by the Ministry of Food and Drug Safety (MFDS) of Korea to provide supplementary data regarding VascoStem.

Read more